Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study

This publication has 45 references indexed in Scilit:

• Characteristics of 44 cervical cancers diagnosed following Pap-negative, high risk HPV-positive screening in routine clinical practice
  Gynecologic Oncology, 2011
• Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
  The Lancet Oncology, 2010
• Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial
  Published by Elsevier ,2010
• Risk estimation for the next generation of prevention programmes for cervical cancer
  The Lancet Oncology, 2009
• HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial
  The Lancet Oncology, 2009
• A review of human carcinogens—Part B: biological agents
  The Lancet Oncology, 2009
• 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests
  Published by Elsevier ,2007
• Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial
  The Lancet, 2007
• Risk assessment to guide the prevention of cervical cancer
  American Journal of Obstetrics and Gynecology, 2007
• Overview of the European and North American studies on HPV testing in primary cervical cancer screening
  International Journal of Cancer, 2006